CROI 2017 Program and Information

Program and Agenda

696 RALTEGRAVIR SWITCH AND BIOMARKERS OF LIVER STEATOSIS ANDMETABOLIC SYNDROME INWOMEN David Reynoso 1 , Anoma Somasunderam 1 , Maitreyee Nigalye 1 , Judith S. Currier 2 , Netanya S. Utay 1 , Jordan E. Lake 3 1 Univ of Texas Med Branch at Galveston, Galveston, TX, USA, 2 Univ of California Los Angeles, Los Angeles, CA, USA, 3 Univ Texas Houston, Houston, TX, USA 697 CHANGES IN LIVER STEATOSIS AFTER SWITCHING EFAVIRENZ TO RALTEGRAVIR: THE STERAL STUDY Juan Macías 1 , Dolores Merino 2 , Francisco Téllez 3 , Federico Pulido 4 , Juan González-Garcia 5 , Manuel Márquez 6 , Antonio Rivero 7 , María Mancebo 1 , Juan A. Pineda 1 , for the RIS-HEP09 1 Hosp Univ de Valme, Sevilla, Spain, 2 Complejo Hospario Univ de Huelva, Huelva, Spain, 3 Hosp Univ de Puerto Real, Cádiz, Spain, 4 Hosp 12 de Octubre, Madrid, Spain, 5 Hosp Univ La Paz, Madrid, Spain, 6 Hosp Virgen de la Victoria, Málaga, Spain, 7 Hosp Univ Reina Sofia, Cordoba, Spain 698 OBESITY IN ANTIRETROVIRAL-TREATED HIV-INFECTED ADULTS: PREDICTORS AND COMORBIDITIES Anchalee Avihingsanon 1 , Sivaporn Gatechompol 1 , Opass Putcharoen 2 , Jiratchaya Sophonphan 1 , Supalak Phonphithak 1 , Sasiwimol Ubolyam 1 , Stephen J. Kerr 1 , Kiat Ruxrungtham 2 , Praphan Phanunphak 1 , for the HIV-NAT 006 Study Group 1 HIV-NAT, Thai Red Cross AIDS Rsr Cntr, Bangkok, Thailand, 2 Chulalongkorn Univ, Bangkok, Thailand 699 WOMEN GAINMOREWEIGHT THANMEN FOLLOWING INITIATION OF ANTIRETROVIRAL THERAPY Sara H. Bares 1 , Laura M. Smeaton 2 , Ai Xu 2 , Catherine Godfrey 3 , Grace A. McComsey 4 1 Univ of Nebraska, Omaha, NE, USA, 2 Harvard Univ, Cambridge, MA, USA, 3 DAIDS, NIAID, Bethesda, MD, USA, 4 Case Western Reserve Univ, Cleveland, OH, USA 700 CT FAT DENSITY REFLECTS HISTOLOGIC FAT QUALITY IN ART- TREATED, HIV-1-INFECTED ADULTS Jordan E. Lake 1 , Carlee Moser 2 , Liz Johnston 2 , Clara Magyar 3 , Scott D. Nelson 3 , Kristine Erlandson 4 , Todd Brown 5 , Grace A. McComsey 6 1 Univ of Texas, Houston, TX, USA, 2 Harvard Univ, Boston, MA, USA, 3 Univ of California Los Angeles, Los Angeles, CA, 4 Univ of Colorado, Aurora, CO, USA, 5 The Johns Hopkins Univ, Baltimore, MD, USA, 6 Case Western Reserve Univ, Cleveland, OH, USA 701 ASSOCIATION OF NAFLDWITH ADIPOKINE AND INFLAMMATORY MARKERS DIFFERS BY HIV STATUS Jennifer Price 1 , Ruibin Wang 2 , Eric Seaberg 2 , Matthew Budoff 3 , Lawrence Kingsley 4 , Frank J. Palella 5 , Mallory Witt 6 , Wendy Post 2 , Chloe Thio 2 1 Univ California San Francisco, San Francisco, CA, USA, 2 The Johns Hopkins Univ, Baltimore, MD, USA, 3 Harbor–UCLA Med Cntr, Torrance, CA, USA, 4 Univ of Pittsburgh, Pittsburgh, PA, USA, 5 Northwestern Univ, Chicago, IL, USA, 6 Los Angeles Biomed Rsr Inst, Harbor–UCLA Med Cntr, Torrance, CA, USA

Poster Sessions • Thursday

CROI 2017 188